scispace - formally typeset
L

Lukas Forer

Researcher at Innsbruck Medical University

Publications -  78
Citations -  11783

Lukas Forer is an academic researcher from Innsbruck Medical University. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 22, co-authored 55 publications receiving 7692 citations. Previous affiliations of Lukas Forer include University of Innsbruck.

Papers
More filters
Journal ArticleDOI

Analyzing Low-Level mtDNA Heteroplasmy—Pitfalls and Challenges from Bench to Benchmarking

TL;DR: In this paper, the authors examined potential pitfalls on the sequencing results based on two-person mtDNA mixtures and compared three DNA polymerases, six different variant callers in five mixtures between 50% and 0.5% variant allele frequencies generated with two different amplification protocols.
Posted ContentDOI

Immune response to 2-dose BNT162b2 vaccination and risk of SARS-CoV-2 breakthrough infection: The Shieldvacc-2 study

TL;DR: Higher plasma levels of binding antibodies and antibodies in a surrogate neutralization assay were associated with reduced risk of breakthrough infection and assessment of anti-spike IgG levels enhanced prediction of breakthrough infections and may be a suitable measurable correlate of protection in practice.
Journal ArticleDOI

A Family and a Genome-Wide Polygenic Risk Score Are Independently Associated With Stroke in a Population-Based Study

TL;DR: This study shows that a family risk score and PGS capture different information concerning individual stroke risk, as demonstrated in a population-based study.
Proceedings ArticleDOI

Cloudflow - A framework for MapReduce pipeline development in Biomedical Research

TL;DR: Cloudflow is presented, a high-level framework to hide the implementation details of Hadoop and to provide a set of building blocks to create biomedical pipelines in a more intuitive way and it will be shown how the framework can be combined with theHadoop workflow system Cloudgene and the cloud orchestration platform CloudMan to provide Hadoops pipelines as a service to everyone.
Journal ArticleDOI

Frequent LPA KIV-2 Variants Lower Lipoprotein(a) Concentrations and Protect Against Coronary Artery Disease.

TL;DR: In this article, up to 70% of the LPA concentrations are a major independent risk factor for coronary artery disease (CAD) and are mainly determined by variation in LPA.